Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Pharmigene, Inc. (7595) Income Statement

Pharmigene, Inc. Income Statement

Last quarter (Q2 2026), Pharmigene, Inc.'s total revenue was NT$68.66M, an increase of 43.47% from the same quarter last year. In Q2, Pharmigene, Inc.'s net income was NT$-20.60M. See Pharmigene, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 199.89MNT$ 116.53MNT$ 132.71MNT$ 133.80MNT$ 129.35M
NT$ 38.91MNT$ 41.47MNT$ 42.54MNT$ 44.73MNT$ 46.05M
NT$ 93.87MNT$ 122.75MNT$ 101.73MNT$ 88.59MNT$ 70.22M
Depreciation and AmortizationNT$ 25.70MNT$ 23.97MNT$ 22.87MNT$ 19.77MNT$ 15.19M
NT$ -29.26MNT$ -46.75MNT$ -41.85MNT$ -22.01MNT$ -6.83M
NT$ -54.96MNT$ -81.28MNT$ -59.19MNT$ -44.45MNT$ -22.73M
NT$ -18.01MNT$ 2.40MNT$ -13.45MNT$ 1.75MNT$ -1.04M
NT$ -72.97MNT$ -82.83MNT$ -72.63MNT$ -42.70MNT$ -23.77M
NT$ -73.00MNT$ -82.86MNT$ -72.65MNT$ -42.72MNT$ -23.43M
Per Share Metrics
Basic EPSNT$ -1.45NT$ -1.64NT$ -1.60NT$ -0.98NT$ -0.54
Diluted EPSNT$ -1.45NT$ -1.64NT$ -1.60NT$ -0.98NT$ -0.54
Weighted Average Shares Outstanding50.34M50.47M45.40M43.47M43.47M
Weighted Average Shares Outstanding (Diluted)50.34M50.53M45.48M43.47M43.47M

Currency in TWD

Pharmigene, Inc. Earnings and Revenue History

-120M0120M240M-75 %-50 %-25 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin